|
YKT6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.515070E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.370400E-04 |
| Normal-vs-Stage2 |
3.143000E-01 |
| Normal-vs-Stage3 |
5.395800E-03 |
| Normal-vs-Stage4 |
2.884800E-03 |
| Stage1-vs-Stage2 |
1.677540E-03 |
| Stage1-vs-Stage3 |
9.480200E-01 |
| Stage1-vs-Stage4 |
2.248400E-01 |
| Stage2-vs-Stage3 |
2.619700E-03 |
| Stage2-vs-Stage4 |
1.222180E-03 |
| Stage3-vs-Stage4 |
2.681200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.790300E-04 |
| Normal-vs-AfricanAmerican |
5.075700E-02 |
| Normal-vs-Asian |
7.632500E-04 |
| Caucasian-vs-AfricanAmerican |
7.880800E-01 |
| Caucasian-vs-Asian |
4.438600E-01 |
| AfricanAmerican-vs-Asian |
4.230800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.538600E-03 |
| Normal-vs-Female |
2.941400E-03 |
| Male-vs-Female |
6.423600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.246000E-04 |
| Normal-vs-Age(41-60Yrs) |
3.438400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.555990E-01 |
| Normal-vs-Age(81-100Yrs) |
4.935000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.982800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.348040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.262400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.667800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.007010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.307000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.928100E-02 |
| Classical-VS-Follicular |
5.522100E-03 |
| Classical-VS-Other |
9.152000E-02 |
| Classical-VS-Normal |
6.229600E-04 |
| Tall-VS-Follicular |
1.446700E-04 |
| Tall-VS-Other |
5.567400E-01 |
| Tall-VS-Normal |
1.74937999999347E-05 |
| Follicular-VS-Other |
2.637900E-02 |
| Follicular-VS-Normal |
9.063200E-01 |
| Other-VS-Normal |
7.385900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.426170E-01 |
| Normal-vs-N1 |
7.93850000000429E-05 |
| N0-vs-N1 |
8.415100E-04 |
|
|
